Hot Keywords
rare disease orphan drug

Top

Rare Disease and Orphan Drugs Journal - A New Member of the Committee on Publication Ethics

Published on: 15 Nov 2022 Viewed: 27

The Editorial Office of Rare Disease and Orphan Drugs Journal (RDODJ) is pleased to announce that the journal has been a member of the Committee on Publication Ethics (COPE). Please see details at: https://publicationethics.org/members/rare-disease-and-orphan-drugs-journal.

COPE, a registered charity established in 1997 in the United Kingdom, has over 12,500 members worldwide from all academic fields. COPE provides advice to Editors and publishers on all aspects of publication ethics and, in particular, how to handle cases of research and publication misconduct.

RDODJ will continuously adhere to the COPE Code of Conduct and follow the Best Practice Guidelines for Journal Editors, ensuring that our Editors enforce a rigorous peer-review process with strict ethical policies.


© 2016-2022 OAE Publishing Inc., except certain content provided by third parties